Xiaohui Zhang

机构：Army Medical University, Peking University, Xinqiao Hospital, Peking University People's Hospital, Air Force Medical University

发表论文 20 篇 · 总被引 241 次 · h-index 6

代表论文

• Multicentre, randomised phase III study of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia (2016 · British Journal of Haematology · 被引 81)
• A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia (2021 · Journal of Hematology & Oncology · 被引 75)
• Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy (2022 · Chinese Medical Journal · 被引 23)
• Single-cell transcriptomics identifies PDGFRA+ progenitors orchestrating angiogenesis and periodontal tissue regeneration (2025 · International Journal of Oral Science · 被引 18)
• Effect of Eltrombopag on Platelet Response and Safety Results in Chinese Adults with Chronic ITP-Primary Result of a Phase III Study (2014 · Blood · 被引 8)
• [Outcome of patients with adult acute lymphoblastic leukemia between 2000 and 2013: experience from single center]. (2015 · PubMed · 被引 6)